10.34 0.001 (0.01%) | 12-26 15:00 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 12.92 | 1-year : | 15.1 |
Resists | First : | 11.06 | Second : | 12.92 |
Pivot price | 9.89 | |||
Supports | First : | 8.52 | Second : | 6.94 |
MAs | MA(5) : | 10.34 | MA(20) : | 10.04 |
MA(100) : | 10.23 | MA(250) : | 10.17 | |
MACD | MACD : | 0 | Signal : | -0.1 |
%K %D | K(14,3) : | 92.9 | D(3) : | 87.6 |
RSI | RSI(14): 53.2 | |||
52-week | High : | 11.06 | Low : | 6.94 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ JAQC ] has closed below upper band by 35.2%. Bollinger Bands are 361.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 37 days. This is a sign that the current trend might continue.
If tomorrow: | Open lower | Open higher |
High: | 10.35 - 10.4 | 10.4 - 10.44 |
Low: | 10.22 - 10.28 | 10.28 - 10.33 |
Close: | 10.25 - 10.34 | 10.34 - 10.42 |
Jupiter Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Hobe Sound, Florida.
Wed, 20 Dec 2023
FILAMENT HEALTH ANNOUNCES TERMINATION OF PROPOSED BUSINESS COMBINATION WITH JUPITER ... - Canada NewsWire
Wed, 20 Dec 2023
Filament Health Cancels SPAC Merger - Green Market Report
Wed, 06 Dec 2023
Filament Health Finds New Financing in Quest for Nasdaq Uplisting - Green Market Report
Tue, 14 Nov 2023
Newswire - VictoriaNow
Tue, 14 Nov 2023
FILAMENT HEALTH AND NASDAQ-LISTED SPAC JUPITER ACQUISITION CORPORATION ANNOUNCE FORM F-4 ... - Canada NewsWire
Thu, 20 Jul 2023
Filament Health Heading to NASDAQ With SPAC Merger - Microdose Psychedelic Insights
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
Exchange:
NASDAQ
|
|
Sector:
Financial Services
|
|
Industry:
Shell Companies
|
|
Shares Out | 6 (M) |
Shares Float | 2 (M) |
Held by Insiders | 69.4 (%) |
Held by Institutions | 23.5 (%) |
Shares Short | 2 (K) |
Shares Short P.Month | 0 (K) |
EPS | -0.44 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | -0.82 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | -1.8 % |
Return on Equity (ttm) | 0 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | -2 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | -23.5 |
PEG Ratio | 0 |
Price to Book value | -12.77 |
Price to Sales | 0 |
Price to Cash Flow | -32.54 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |